This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube
- Starting date:
- November 19, 2012
- Posting date:
- January 7, 2013
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public (GP), Healthcare Professionals, Hospitals
- Identification number:
- RA-16631
Recalled Products
A. BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube
Reason
There is evidence that in a portion of the affected lot there is a cross-contamination with lithium heparin, in a concentration not exceeding 1.2 iu per milliliter in plasma obtained from properly filled tubes (note: this value was obtained from healthy subjects using a limited number of tubes from the affected lot). The internal investigation completed by bd indicates that this contaminant can adversely affect coagulation results. Erroneous results may lead to inappropriate decisions regarding patient care. For a full listing of assays that may be adversely affected by the lithium heparin contaminant, please contact the manufacturer.
Affected products
A. BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube
Lot or serial number
2180434
Model or catalog number
363083
Companies
- Manufacturer
-
Becton Dickinson and Company